The effect of flammer-syndrome on retinal venous pressure
BMC Ophthalmology
The effect of flammer-syndrome on retinal venous pressure
Lei Fang 0 1
Michael Baertschi 0
Maneli Mozaffarieh 0
0 Department of Ophthalmology, University of Basel , Mittlere Strasse 91, 4031 Basel , Switzerland
1 Department of Biomedicine, University of Basel , Basel , Switzerland
Background: The purpose of the study was to measure the retinal venous pressure (RVP) in the eyes of primary open-angle glaucoma (POAG) patients and healthy subjects with and without a Flammer-Syndrome (FS). Methods: RVP was measured in the following four groups of patients and age- and sex-matched healthy controls: (a) 15 patients with a POAG and a FS (POAG/FS+); (b) 15 patients with a POAG but without a FS (POAG/FS-); (c) 14 healthy subjects with a FS (healthy/FS+) and (d) 16 healthy subjects without a FS (healthy/FS-). RVP was measured in all participants bilaterally by means of contact lens ophthalmodynamometry. Ophthalmodynamometry is done by applying increasing pressure on the eye via a contact lens. The minimum force required to induce a venous pulsation is called ophthalmodynamometric force (ODF). The RVP is defined and calculated as the sum of ODF and intraocular pressure (IOP) [RVP = ODF + IOP]. Results: The participants with a FS (whether patients with POAG or healthy subjects), had a significantly higher RVP compared to subjects without a FS (p = 0.0103). Patients with a POAG and FS (POAG/FS+) had a significantly higher RVP compared to patients without a FS (POAG/FS) (p = 0.0301). There was a notable trend for a higher RVP in the healthy/FS + group compared to the healthy/FS group, which did not reach statistical significance (p = 0.0898). Conclusions: RVP is higher in subjects with a FS, particularly in glaucoma patients. The causal relationship needs to be further evaluated.
-
Background
Disturbances of ocular blood flow are involved in many
ophthalmic diseases and are therefore of utmost clinical
relevance [1-5]. There are various causes for blood flow
disturbances, such as diseased blood vessels [6] or
mechanical compression of the vessel wall [7]. However, some
organs are not well perfused, despite anatomically
healthy blood vessels, when the regulation of blood flow
is not adapted to the needs of the tissue [8]. Such a
vascular dysregulation implies either inappropriate
vasoconstrictions (vasospasms) or an insufficient vasodilation
(more or less than is required) [9]. Dysregulation can be
secondary in nature, as in multiple sclerosis [10], wherein
the high level of Endothelin-1 reduces ocular blood flow
OBF. Dysregulation can also be primary in nature
(primary vascular dysregulation or PVD) [9], meaning that it
can occur without any underlying disease and caused by
an inborn tendency to respond differently to various
stimuli, such as cold temperatures or mechanical or emotional
stress. The combination of PVD with a cluster of
additional vascular and non-vascular signs and symptoms is
what is known today as the Flammer-Syndrome [11,12].
The eye is one of the best-perfused organs in the body.
One factor influencing this process is the ocular
perfusion pressure (OPP) [13-17]. OPP is the difference
between systemic blood pressure and the RVP. In the
eye, arterial pressure is assumed to be 2/3 of the brachial
arterial pressure. The RVP is assumed equal to the IOP.
The latter assumption is not always true in glaucoma
patients [18-21].
As summarized in the literature reviews, glaucoma
patients often concomitantly suffer from a FS [22,23]. One
of the clinical observations that we made in patients
with a FS was that they often had dilated retinal veins,
which is why we hypothesized that RVP may be higher
in FS than in non-FS subjects. We therefore set out to
measure RVP in glaucoma patients and healthy subjects
with and without a FS.
Methods
Patients with POAG were recruited from the University
Eye Clinic, Basel, between January 2011 and December
2012. Healthy volunteers, age- and sex-matched to the
POAG patients, were recruited in our outpatient
department. The control subjects did not have any relevant eye
disease and attended our outpatient department for
various reasons, including prescriptions for eyeglasses, dry
eye symptoms and regular ophthalmic check-up
examinations. Ethical approval was obtained from the local
medical ethics committee of Basel City (Ethik Kommission
Beider Basel or EKBB) to measure RVP in healthy controls
who gave oral consent to take part in the study (Reference
Number 272/11). No ethical approval was required to
measure RVP in glaucoma patients as RVP measurements
are always taken in all glaucoma patients at the
Department of Ophthalmology of the University of Basel. For
inclusion, the patients with POAG met the following criteria:
(1) glaucomatous visual fields or glaucomatous optic nerve
cupping and (2) the absence of alternative causes of optic
neuropathy.
FS was defined as being present if it was detected in
the patient history and confirmed by the dynamic retinal
vessel analyser (DVA). Cases in which the patient history
and DVA results were contradictory were excluded from
the study.
Evaluation of patient history for FS
FS is defined as present (FS+) in the patient history if the
subjects answer three of the following six questions with
Yes, and it is defined as absent (FS-) if the subjects
answer less than three questions with Yes: 1) Do you suffer
from cold hands or feet even in summer [24]?; 2) Do you
have trouble falling asleep, especially when you are cold
[25]?; 3) Are you seldom thirsty, and do you have to
remind yourself to drink enough [26]?; 4) Do you suffer from
migraine attacks [27]?; 5) Do you have low blood pressure
[28]?; 6) Do you identify smells better than others [29]?
Evaluation of DVA results for FS
The results of DVA were considered positive for FS
(pathological) if the reaction of the arteries in both eyes
was reduced in response to flickering light.
Cases in which the patient history and DVA results
were contradictory were excluded from the study. The
following groups of subjects were compared: (1) POAG
patients with a FS (POAG/FS+); (2) POAG patients
without a FS (POAG/FS); (3) healthy controls with a
FS (healthy/FS+) and (4) healthy controls without a FS
(healthy/FS). Table 1 presents the demographic data of
the different groups of subjects. Table 2 lists the local
and systemic treatment regimens of the POAG patients.
For all patients and controls, RVP was measured in
both eyes by ophthalmodynamometry (Meditron GmbH,
Table 1 Demographic and baseline characteristics of the
four groups of participants
Age Mean (SD) 67.0 (8.7)
IOP Mean (SD) 10.6 (1.5)
13.33 (2.55) 11.71 (1.33)
Patients with POAG and FS: POAG/FS +.
Patients with POAG but without FS: POAG/FS .
Healthy subjects with FS: Healthy/FS + .
Healthy subjects without FS: Healthy/FS .
Vlklingen, Germany). This device consists of a
conventional Goldmann contact lens fitted with a pressure
sensor at its outer margin where the Goldmann cont (...truncated)